Biodesix Inc
NASDAQ:BDSX

Watchlist Manager
Biodesix Inc Logo
Biodesix Inc
NASDAQ:BDSX
Watchlist
Price: 1.48 USD 1.37% Market Closed
Market Cap: 215.3m USD
Have any thoughts about
Biodesix Inc?
Write Note

Operating Margin
Biodesix Inc

-52.7%
Current
-102%
Average
4.1%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-52.7%
=
Operating Profit
-34.6m
/
Revenue
65.6m

Operating Margin Across Competitors

Country US
Market Cap 215.3m USD
Operating Margin
-53%
Country US
Market Cap 75.6B EUR
Operating Margin
4%
Country US
Market Cap 77.9B USD
Operating Margin
4%
Country US
Market Cap 56B USD
Operating Margin
3%
Country DE
Market Cap 26B EUR
Operating Margin
7%
Country DE
Market Cap 18.9B EUR
Operating Margin
7%
Country US
Market Cap 19.3B USD
Operating Margin
9%
Country US
Market Cap 17.7B USD
Operating Margin
8%
Country US
Market Cap 17.1B USD
Operating Margin
14%
Country DE
Market Cap 13B EUR
Operating Margin
7%
Country US
Market Cap 12.7B USD
Operating Margin
15%
No Stocks Found

Biodesix Inc
Glance View

Market Cap
215.3m USD
Industry
Health Care

Biodesix, Inc. provides blood-based diagnostics services for patients with lung disease. The company is headquartered in Boulder, Colorado and currently employs 218 full-time employees. The company went IPO on 2020-10-28. The firm uses its artificial intelligence (AI) platform, Diagnostic Cortex, to discover, develop, and commercialize solutions for clinical unmet needs, with a primary focus on lung disease. In addition to its diagnostic tests, it provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development and commercialization of companion diagnostics. The firm offers blood-based lung cancer tests across the lung cancer continuum of care, including Nodify XL2 and Nodify CDT tests, and GeneStrat and VeriStrat tests. The firm also offers three SARS-CoV-2 tests under the Biodesix WorkSafe testing program, such as Bio-Rad SARS-CoV-2 ddPCR test, Platelia SARS-CoV-2 Total Ab test and cPass SARS-CoV-2 Neutralization Antibody Test.

BDSX Intrinsic Value
1.96 USD
Undervaluation 24%
Intrinsic Value
Price

See Also

Discover More
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-52.7%
=
Operating Profit
-34.6m
/
Revenue
65.6m
What is the Operating Margin of Biodesix Inc?

Based on Biodesix Inc's most recent financial statements, the company has Operating Margin of -52.7%.